Prof. Heidi Williams speaks with Callie Crossley as part of WGBH’s “Genius Next Door” series, which features local winners of the MacArthur “genius grant.” Williams explains that her work focuses on “whether we're getting the right kinds of medical technologies developed.”
Senior Lecturer Phil Budden writes for Fortune about how the Greek financial crisis also presents an opportunity. Budden recommends that Greece, “shift its focus away from its macroeconomic problems and toward the task of creating an innovation ecosystem.”
Prof. Heidi Williams, a 2015 MacArthur Fellow, speaks with Bloomberg’s John Tozzi about why drug companies are underinvesting in long-term research. Williams explains that there are “scientifically feasible projects that aren’t getting done because there aren’t sufficient incentives."
Boston Globe reporter Kathleen Burge speaks with Prof. Heidi Williams, a 2015 MacArthur fellow, about how she felt upon learning she had been honored by the MacArthur Foundation and her research examining technological change in the health care market. “It’s quite overwhelming to hear this news and to get that vote of support,” said Williams.
Prof. Heidi Williams has been named a 2015 MacArthur “Genius” award winner, according to the Associated Press. Williams was honored for her research exploring, “the causes and consequences of innovation in health care markets.”
In an article for The New York Times about the impact of patent laws on drug development, Austin Frakt highlights Prof. Benjamin Roin’s research that indicates pharmaceutical companies reject unpatentable drugs. To counter this problem, Frakt explains that Roin suggests “a period of market exclusivity…to any organization addressing an unmet medical need with a drug that isn’t patentable.”
Bruce Arntzen, the executive director of MIT’s Supply Chain Management Program, writes for The Wall Street Journal that companies have to take steps to make their supply chains more resilient to economic downturns. “We know a recession will hit at some point but do little to get ready for the impending storm,” argues Arntzen.
A new study co-authored by Prof. Jonathan Gruber found that while Quebec’s low-cost child-care system may help children academically, students who participate in the program may “have worse outcomes when it comes to health, life satisfaction and crime rates,” reports Jordan Press for The Huffington Post.
Bourree Lam reports for The Atlantic on an interactive map of U.S. counties produced using Prof. Amy Glasmeier’s Living Wage Calculator. “Glasmeier says that firms can use it to estimate how to pay their employees fairly,” writes Lam.
Ana Swanson reports for The Washington Post on an interactive map created by Prof. Amy Glasmeier that displays the gap between minimum wages and living wages across the U.S. The map shows that the East Coast “is one of the most challenging places for minimum-wage workers to make ends meet.”
Using their “Living Wage Calculator,” Prof. Amy Glasmeier’s team has created a map of the communities in the U.S. that have the widest gaps between living wages and minimum wages, reports Rob Wile for The Huffington Post.
Boston.com reporter Megan Turchi writes that MIT researchers have developed a map that compares the cost of living and minimum wage for households across the U.S. Prof. Amy Glasmeier explains that one of her goals for the map is to “to inspire policy makers to step up and ensure their wage scales were livable.”
Prof. Andrew Lo speaks with Michael Regan of Bloomberg News about the recent volatility in the stock market. “We have a number of different forces that are all coming to a head,” explains Lo. Due to automated trading “we’re seeing much choppier markets than we otherwise would have five or 10 years ago.”
New research by Prof. Andrew Lo shows that the criteria currently used to evaluate whether drugs are safe and effective is too strict, reports Carolyn Johnson for The Washington Post. The study suggests that, “for many devastating diseases, the current standards are too risk-averse, erring on the side of keeping drugs off the market.”
Prof. Yasheng Huang writes for The Boston Globe about the Chinese government’s active role in the country’s economy and how this is negatively impacting growth. “Chinese growth in the future will be limited until the government makes fairly substantive structural reforms,” writes Huang.